The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...

Clearmind Medicine shares dropped in after-hours trading following the company's announcement of a 1-for-40 reverse stock ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...

Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for ...

Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary ...

A drug launch is one of the most defining events in the pharma and biotech lifecycle. It marks the moment a therapy moves ...

Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...

Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Read more at The ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...